43
Participants
Start Date
May 17, 2022
Primary Completion Date
August 8, 2022
Study Completion Date
August 8, 2022
COVID-19 mRNA vaccine
2 doses of vaccine on Day 0 and Day 21
Placebo
2 doses of placebo on Day 0 and Day 21
Beijing Friendship Hospital, Beijing
Hebei Petro China Center Hospital, Langfang
Hunan Provincial Center for Disease Control and Prevention, Changsha
Lead Sponsor
CanSino Biologics Inc.
INDUSTRY